Please login to the form below

Not currently logged in
Email:
Password:

Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare

Moves into business development director role at the group

Wilmington Healthcare Matthew KirbyHealthcare information group Wilmington Healthcare has appointed Matthew Kirby as business development director.

He will lead a team of business development managers focused on areas such as multichannel marketing and NHS service redesign and join from Janssen Pharmaceuticals.

Gareth Thomas, managing director of Wilmington Healthcare, said: “We are very pleased to welcome Matthew to his new post, where he will play a pivotal role in supporting and enhancing the work of the business development team.

“Having spent many years working in the pharma industry in sales, market access and business development roles, Matthew has a wealth of knowledge and experience, and he will be a very valuable asset to the team.”

Kirby sent seven years at the pharma firm, most recently serving as regional business manager in the UK for its diabetes sales team across the south east.

Prior to that his roles included multichannel manager, customer and field support team manager and health economy liaison manager.

Before joining Janssen Kirby was at Nycomed Pharmaceuticals, where he served in a market access capacity as a healthcare development specialist.

20th December 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics